Michael Schuster in Sewell, New Jersey

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Wisconsin School Of Medicine
Graduation Year: 2002
The Primary Medical Specialty for Michael Schuster is listed as: Rheumatology
Approximate Years of Experience: 22
PAC (PECOS ID)#: 6002987203
NPI #: 1215091269
NPI Created On: 12/21/2006
NPI Last Updated Listed as: 05/16/2018
Primary Taxonomy Code: 207RR0500X
License Number:
25MA08543700
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• AmeriHealth New Jersey
• Blue Cross Blue Shield
• Humana
• Oscar Garden State Insurance Corporation
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
4. Infusion of chemotherapy into a vein up to 1 hour
5. Infusion of chemotherapy into a vein
6. New patient office or other outpatient visit, typically 30 minutes
7. New patient office or other outpatient visit, typically 45 minutes
8. Established patient office or other outpatient visit, typically 15 minutes
9. Established patient office or other outpatient, visit typically 25 minutes
10. Physician telephone patient service, 11-20 minutes of medical discussion
11. Physician telephone patient service, 21-30 minutes of medical discussion
12. Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
13. Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
14. Injection, denosumab, 1 mg
15. Injection, methylprednisolone acetate, 20 mg
16. Injection, methylprednisolone acetate, 40 mg
17. Injection, golimumab, 1 mg, for intravenous use
18. Injection, infliximab, excludes biosimilar, 10 mg
19. Injection, tocilizumab, 1 mg
20. Injection, triamcinolone acetonide, not otherwise specified, 10 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).